Heart Disease
Fibromyalgia
High Cholesterol Danger?
Toxic Metals
Free Radicals -- Primer
IV Chelation Therapy

Wrong Diet Causes Diabetes

Vibrant Life Home Web
Family Of Three Oral Chelation Formulas
The Wednesday Letter
The Hubbard Human Detoxification Program
Hopeless Diseases -- Invented to Sell Drugs
Wrong Relationship Cause of Disease

Brain Chemical Imbalance
Dr. Garry F. Gordon
Ultimate Resource On Chelation Therapy Home Page

Shopping Cart

Separate Search Page
or search below

Loading
Prevent Cancer

Oral Chelation Therapy
Other

Karl Loren's Policy On Psychiatric Drugs
Destruction Of American Education
Write To Karl Loren Table Of Contents

New Class of Cancer Drugs Could Cause Brain Damage

Write To Karl Loren About This Page

Source

The Wall Street Journal  

October 18, 2002 12:48 a.m. EDT

HEALTH
MAD COW ARTICLES
 

 Brain Illness Tied to Mad Cow Is Reported in Florida Woman3
04/19/02

 
 The U.S. May Face Mad-Cow Exposure Despite Assurances From Government4
11/28/01

 
 Drugs Show Promise For Mad-Cow Variant5
08/14/01
 
 Doctors See Promising Results Treating Human Form of Mad-Cow Disease6
08/13/01
 
 



COMPANIES
Dow Jones, Reuters
Millennium Pharmaceuticals Inc. (MLNM)
PRICE
CHANGE
U.S. dollars
7.73
-0.26
12:07 p.m.


 
 

* At Market Close

New Class of Cancer Drugs Could Cause Brain Damage

By ANTONIO REGALADO
Staff Reporter of THE WALL STREET JOURNAL
 

Scientists studying brain-wasting diseases linked to mad cow have warned that a new class of cancer drugs have the potential to set off similar brain deterioration.

The new cancer-treatment compounds, known as proteasome inhibitors, block cell machinery used to digest unwanted proteins. But the researchers, led by Susan Lindquist, a professor at the Massachusetts Institute of Technology, said using such compounds in mice helped produce brain-wasting symptoms.

Drugs in the class include Velcade, which is being tested in patients by Millennium Pharmaceuticals, Cambridge, Mass., and the National Cancer Institute. David Schenkein, vice president for clinical oncology at Millennium Pharmaceuticals, said the findings weren't viewed as cause for concern because the drug isn't able to cross into the brain.

[Karl Note:  You can be certain that some adverse publicity on a drug under development by some drug company will be met with denials of applicability by the company. You can also be hopefully sure that a vigorous core of media journalists will sniff out these negative reports to keep the public informed -- the drug companies will certainly NOT publicize these reports -- but will hide them if they can.]

Millennium's is the only proteasome-inhibitor cancer drug to enter human tests, said John Wright, a senior clinical investigator at the National Cancer Institute. The federal cancer institute said it had 28 studies with the drug ongoing in different types of cancer.

After learning of the possible risk, the NCI held several meetings during the summer with experts in prion disease and from the Food and Drug Administration, said Louise Grochow, a senior manager at the National Cancer Institute. Dr. Grochow said the risk was deemed small, and that no significant changes would be made to the design of the studies. However, she added that the NCI would require more thorough neurological evaluation of patients. "So far, there is no evidence that the risk is being played out," said Dr. Grochow.

Proteasome inhibitors aren't the same as protease inhibitors, drugs that are used widely to treat HIV infection and AIDS.

Dr. Lindquist and co-workers found the proteasome effect while studying the molecular basis of prion diseases, which include mad cow and variants that affect humans and deer.

The diseases have been linked to misshapen prion proteins, which accumulate around nerve cells killed off by the condition. However, Dr. Lindquist reports Friday in the journal Science that normal prion proteins were able to cause nerve degeneration when they were present inside a cell's liquidy interior, or cytoplasm.

The proteins were able to accumulate after the scientists applied proteasome-blocking chemicals to the cells. The proteasome is the cellular machinery that normally digests proteins.

The cause of the brain disease has been a major scientific question, and Dr. Lindquist said her paper suggested a possible explanation, though conclusive proof was lacking. Jiyan Ma of Ohio State University, who carried out much of the work, said it could be that one form of the prion protein causes the symptoms, while another form lets it pass between animals. "We think the transmission and the toxicity are separate," said Dr. Ma.

Write to Antonio Regalado at antonio.regalado@wsj.com2

URL for this article:
http://online.wsj.com/article/0,,SB1034900222795077788.djm,00.html

 
Hyperlinks in this Article:
(1) http://wsj.com/health
(2) mailto:antonio.regalado@wsj.com
(3) http://online.wsj.com/article/0,,SB1019176878832543760,00.html
(4) http://online.wsj.com/article/0,,SB1006897773680759520,00.html
(5) http://online.wsj.com/article/0,,SB997740662233999414,00.html
(6) http://online.wsj.com/article/0,,SB997646998585384526,00.html

Updated October 18, 2002 12:48 a.m. EDT

Copyright 2002 Dow Jones & Company, Inc. All Rights Reserved

Printing, distribution, and use of this material is governed by your Subscription agreement and Copyright laws.

For information about subscribing go to http://www.wsj.com
 

Special Pages On The Various of 19 Web Sites Authored by Karl Loren
OC History Oral Chelation Testimonials
Family Of Three Oral Chelation Formulas Life Glow Basic Life Glow Basic Ingredient List
Life Glow Plus Life Glow Plus
Ingredient List
American Heart Association -- Lies
Super Life Glow Super Life Glow
 Ingredient List
FAQ
All Products Shopping Cart Order Section Research
Taheebo Life Tea Witch Doctors Versus Harvard MSM Sulfur
Calcium How Bones Grow Colloidal Minerals
Jean Ross Philosophy The Wednesday Letter
Arthritis & James Coburn's Use Of MSM Karl Loren Viewpoints News And Announcements
Dr. Flanagan's Microhydrin 500 Page Book On Heart Disease Colostrum & Transfer Factor
Germanium Ultrasound Technology Bulk MSM
Cancer & Biopsy Diabetes Heart Disease & Bypass Surgery
Karl Loren's Diet Guarantee High Cholesterol Risk?
The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents Search This Web Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally.  Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web Vibrant Life Web Karl Loren's Book
Super Colostrum Bulk MSM Heart Disease
Emmessar Happiness Arthritis
Instead Of Chelation Therapy Super Colostrum (2)
Immune Egg Central Page For All 19 Webs!
 

I promise to answer your message -- click here to send me a personal message

Dear Karl,                                        

 

 

 

 

SUBSCRIBE:  The Vibrant Life Magazine is a free electronic weekly newsletter written and published by Vibrant life.  You can view more than 50 back issues of this publication by clicking here.  The newsletter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.  The letter has been changed to product and information news which is sent out regularly each week.

E-Mail Address:
First Name:
Last Name:

REMOVAL:  You can remove yourself from the subscription list in several different ways.  Click here to read about this entire newsletter system.  Every edition of Product and Information Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.  If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.  Thus, no one else can unsubscribe you, from some other computer, without your knowledge.  But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

E-Mail Address:

Personal Message:  When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.  Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.  You can select particular information you would like to receive, along with the free cassette tape and catalog.

You can reach Vibrant Life in many ways, including by mail to Vibrant Life, PO Box 10666, Burbank, CA 91510-0666.  Within the US and Canada, use the toll free number:  (800) 523-4521, the local number:  (818) 558-7099, eMail to barb@oralchelation.com or any one of the hundreds of message forms throughout the 60 web sites.  Vibrant Life normally ships the same day we get an order.  There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.  Check out our companion site, at:  http://www.oralchelation.net where Karl's 2000 page book is published.  Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION.  His personal philosophical articles are at PHILOSOPHY

Copyright © May 23, 2012 4:51 PM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.  Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:  One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site.  This permission does not extend to materials on this site which are copyrighted by others.